Agglomerated Sucroferric Oxyhydroxide Micro-Tablet Ejection Marks

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing sucroferric oxyhydroxide compositions used in micro-tableting lead to dark brown marks on the extremities of micro-tablets due to higher ejection forces, making it challenging to produce smaller tablets suitable for pediatric applications or patients with dysphagia.

Innovation Solution

Subjecting the sucroferric oxyhydroxide particles obtained by spray drying to agglomeration, resulting in a coarser particle size distribution with a higher fraction of particles above 90 μm and 125 μm, which allows for the manufacture of smaller tablets, such as micro- or mini-tablets, without the formation of marks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If spray-dried sucroferric oxyhydroxide particles are used in micro-tableting, then the tablets can be produced, but dark brown marks appear on the extremities due to high ejection forces

Engineering Contradiction:
Improvemicro-tablet productionVSAvoiddark brown marks on tablet extremities
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent changes the particle size distribution parameter by agglomerating spray-dried particles to achieve a coarser distribution (d10: 45-75 μm, d50: 90-150 μm, d90: 150-250 μm). This parameter change reduces ejection forces during micro-tableting, preventing dark brown marks on tablet extremities while maintaining manufacturability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies preliminary agglomeration treatment to the spray-dried particles before micro-tableting. This preliminary action modifies the particle characteristics in advance, ensuring that the particles have suitable size distribution and flow properties that prevent mark formation during the subsequent compression and ejection process

Inventive Principle:
Principle #10Preliminary action

2Volume of moving object

If particle size is reduced for pediatric applications, then smaller tablets can be produced, but ejection forces increase causing manufacturing defects

Engineering Contradiction:
Improvetablet sizeVSAvoidejection forces
Core Design Contradiction:
Volume of moving objectVSForce

Solution Approach 1:

The patent optimizes the particle size distribution parameters through agglomeration to achieve a coarser distribution than conventional spray-dried particles. This parameter optimization enables the production of smaller tablets (micro-tablets) with reduced ejection forces, solving the contradiction between tablet size reduction and ejection force increase

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates agglomerated particle composites by combining multiple spray-dried particles into larger agglomerates with controlled size distribution. This composite structure maintains the beneficial properties of spray-dried particles while achieving the coarser size distribution needed for reduced ejection forces in micro-tablet production

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The agglomerated sucroferric oxyhydroxide particles enable the production of smaller tablets with reduced ejection forces, preventing dark brown marks and ensuring the tablets can be effectively compressed into micro- or mini-tablet form.

Implementation Method 1

when the known sucroferric oxyhydroxide particles obtained by spray drying were subjected to agglomeration leading to a decrease of smaller particles and an increase of bigger particles

Methodology Applied
Scientific EffectAgglomeration: Coagulation

Data Source

PatentUS12329778B2Particles of a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide
Publication Date: 2025.06.17 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
  • US12329778B2 patent drawing
  • US12329778B2 patent drawing

AI summary

The invention relates to particles of a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide having a certain particle size distribution, a process for the manufacture thereof, the pharmaceutical composition comprising the same, in particular compressed tablets.